2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

John K. Forrest(Yale University), Michael J. Reardon(Houston Methodist), Basel Ramlawi, Ayman Iskander(St Joseph's Hospital Health Center), Hemal Gada(University of Pittsburgh Medical Center), Ronald Caputo, G. Michael Deeb(Michigan Medicine), George L. Zorn(The University of Kansas Health System), Neal S. Kleiman(Houston Methodist), Antony Walton, John Heiser(Corewell Health), Abeel A. Mangi(Brigham and Women's Hospital), Thomas G. Gleason(Asheville Cardiology Associates), Tanvir Bajwa(Aurora Health Care), Daniel O’Hair(UPMC Health System), Stanley Chetcuti(University of Michigan), Paul Sorajja(Abbott Northwestern Hospital), Jae K. Oh(Mayo Clinic), Joshua D. Rovin(Morton Plant Hospital), Didier Tchétché(Clinique Pasteur), William Merhi(Corewell Health), Jian Huang(Medtronic (United States)), Peter Tadros(The University of Kansas Health System), Mubashir Mumtaz(University of Pittsburgh Medical Center), Paul S. Teirstein(Scripps Health), Steven J. Yakubov(OhioHealth), Douglas Spriggs, Jon R. Resar(Johns Hopkins University)
Journal of the American College of Cardiology
February 28, 2022
Cited by 91


Related Papers